Cite
HARVARD Citation
Stein, M. et al. (2019). Phase II Trial of Eribulin in Patients With Metastatic Hormone Refractory Prostate Cancer. American journal of clinical oncology. p. . [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Stein, M. et al. (2019). Phase II Trial of Eribulin in Patients With Metastatic Hormone Refractory Prostate Cancer. American journal of clinical oncology. p. . [Online].